ABX-196 Uses, Dosage, Side Effects and more
ABX-196 is under investigation in clinical trial NCT03897543 (ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma).
| Trade Name | ABX-196 |
| Generic | ABX-196 |
| Type | |
| Formula | C50H98N2O9 |
| Weight | Average: 871.339 Monoisotopic: 870.727232744 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
